Final Answer:
For mealtime coverage in a client with diabetes starting on insulin therapy, the nurse will discuss using short-acting insulin, such as D.Lispro.
Step-by-step explanation:
Lispro is a rapid-acting insulin analog that is specifically designed for mealtime coverage. Unlike regular insulin, Lispro has a quicker onset of action, reaching the bloodstream faster after injection. This rapid action is crucial for managing postprandial blood glucose levels, providing a more effective way to control spikes in blood sugar that occur after meals.
When a person with diabetes eats, their blood sugar levels tend to rise, and using a short-acting insulin like Lispro helps to address this increase in a timely manner. The goal is to mimic the body's natural insulin response to a meal, helping to control blood sugar fluctuations. Lispro is often preferred over regular insulin for mealtime coverage due to its faster onset and shorter duration of action.
Educating the client about the appropriate use of Lispro, including the timing of injections in relation to meals, is an essential aspect of insulin therapy initiation. The nurse will guide the client on how to incorporate Lispro into their daily routine to achieve optimal blood glucose control and overall diabetes management.
So correct option is D.Lispro